Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors

The American journal of managed care

Volumn 21, Issue 11, 2015, Pages S212-S220

  Epstein, Murray ^a   Reaven, Nancy L ^a   Funk, Susan E ^a   McGaughey, Karen J ^a   Oestreicher, Nina ^a   Knispel, John ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; CHEMICALLY INDUCED; COMORBIDITY; DIABETES COMPLICATIONS; DOSE RESPONSE; DRUG EFFECTS; ELECTRONIC HEALTH RECORD; FEMALE; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPERTENSION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; RENAL INSUFFICIENCY, CHRONIC; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COMORBIDITY; DIABETES COMPLICATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRONIC HEALTH RECORDS; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; HYPERKALEMIA; HYPERTENSION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 85011968147     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Article

References (0)